PLNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Planet Fitness is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has already suffered a major reset, and while the current price is near support and hedge funds are buying, the trend is still weak, analyst targets have been cut sharply, and the company is dealing with slower member growth and lower guidance. For an impatient investor who does not want to wait for a better entry, this is still not a clean buy today.
PLNT is in a mixed-to-bearish technical setup. The MACD histogram is positive and expanding, which suggests some short-term momentum recovery. However, RSI_6 at 52 is neutral, and the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is still down. Pre-market price is 52.58, just below the pivot at 52.068 and under resistance at 54.311, meaning the stock is still fighting overhead supply. The nearby support zone is 49.826, so downside risk remains if momentum fades.
["Hedge funds are buying, with buying up 463.72% over the last quarter.", "Some analysts still maintain Buy/Outperform ratings and see longer-term upside from the franchise model.", "Options positioning is bullish, with call interest materially exceeding put interest.", "MACD is improving, suggesting near-term momentum may be stabilizing."]
["The stock fell about 31% on May 7 after poor member growth and reduced revenue guidance.", "Planet Fitness admitted a marketing misstep that alienated core customers.", "News flow is dominated by securities fraud investigations after the drop.", "Analysts have broadly slashed price targets, signaling weaker expectations.", "Trading pattern suggests negative near-term performance risk over the next month."]
Latest quarter: Q1 2026. Financially, the quarter was weak on growth. Net member growth was slower than expected, same-club sales growth was revised down to 1%, and revenue growth guidance was cut from 9% to 7%. The company also paused a planned price increase, which pressured margin expectations. For a long-term investor, the issue is not survival but slower growth and less visibility than before.
Analyst sentiment is still mixed but clearly deteriorating. Since May 8-20, multiple firms cut price targets sharply: Roth to $64 from $109, UBS to $79 from $120, Stifel to $80 from $90, RBC to $55 from $85, Raymond James to $54 from $101, Morgan Stanley downgraded to Equal Weight with a $47 target, Deutsche Bank to $61 from $98, Guggenheim to $95 from $126, Canaccord to $80 from $122, and Wells Fargo to $65 from $80. The Wall Street pros remain split: bulls argue the franchise model and long-term unit expansion still offer upside, while bears say the pricing and growth case has been damaged and visibility is low. Overall, the consensus tone has turned cautious-to-negative on the near term, even though several firms still keep Buy ratings.
